Multimodal therapy of gastric cancer

Digestive Diseases

Volumn 28, Issue 4-5, 2010, Pages 615-618

  Mlkvý, Peter ^a  

^a St Elisabeth Cancer Institute   (Slovakia)

Author keywords

Adjuvant chemoradiotherapy; Advanced gastric cancer; D1 D2 lymphadenectomy; Early gastric cancer; Neoadjuvant chemotherapy; New therapeutic agents; Total vs. subtotal gastrectomy

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; TRASTUZUMAB;

ABSCESS; ADVANCED CANCER; ANASTOMOSIS DEHISCENCE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; EARLY CANCER; HUMAN; LUNG INFECTION; LYMPH NODE DISSECTION; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; OSTEOPOROSIS; PALLIATIVE THERAPY; PANCREATITIS; PARTIAL GASTRECTOMY; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SPLENECTOMY; STOMACH CANCER; THROMBOEMBOLISM; TOTAL STOMACH RESECTION;

ANIMALS; COMBINED MODALITY THERAPY; HUMANS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 78649356097     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320063     Document Type: Conference Paper

References (20)

1. Parkin DM, Bray FI, Devessa SS: Cancer burden in the year 2000.The global picture. Eur J Cancer 2001; 37: 4-68.
2. Craanen ME, Dekker W, Blok ME: Time trends in gastric carcinoma: changing pattern and location. Am J Gastroenterol 1992; 87:552-559.
3. Adachi Y, Kitano S, Sugimachi K: Surgery for gastric cancer: 10 years experience worldwide. Gastric Cancer 20 01; 4: 166-174.
4. Guildford P, Hopkins J, Harraway J, et al: E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 6674-6679.
5. Bozetti F, Marubini E, Bonfanti G: Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Group. Ann Surg 1999; 230: 170-182.
6. Gouzi JL, Huguier M, Fagniez PL: Total versus subtotal gastrectomy for adenocarci-noma of the gastric antrum. A French prospective control study. Ann Surg 1989; 209: 162-181.
7. Sasako M, Sano T, Yamamoto S: D2 lymph-adenectomy alone or with para-aortic dissection for gastric cancer. N Engl J Med 2008; 359: 453-466.
8. National Comprehensive Cancer Network (NCNN) Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/ physicians-gls/f-guidelines.asp (accessed May 12, 2010).
9. Csendes A, Burdiles P, Rojas J: A prospective randomized study comparing D2 total gas-trectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric cancer. Surgery 2002; 131: 401-410.
10. Bonenkamp JJ, Hermans J, Sasako M, Van de Velde CJH: Extended lymph node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914.
11. Kasakura Y, Fujii M, Mochizuku F, Kochi M, Maiga T: Is there a benefit of pancreatosple-nectomy with gastrectomy for advanced gastric cancer? Am J Surg 20 00; 17 9 : 237-242.
12. Pertl A, Jagoditsch M, Jatzko GR, Denk H, Stettner HM: Long-term results of early gastric cancer accomplished in a European institution by Japanese-type of radical resection. Gastric Cancer 1999; 2:115-121.
13. Kojima T: Outcome of endoscopic mucosal resection for early gastric cancer. Gastroin-test Endosc 1998: 48;550-559.
14. Maakuchi T: Surgical versus endoscopic treatment for early gastric cancer. J Surg Oncol 1998; 17: 108:108-116.
15. Ouchi E, Yamaguchi T, Sawai K, Ohara M, Takahashi T: Therapeutic significance of palliative operations for gastric cancer and quality of life. J Surg Oncol 1998; 69:41-46.
16. Wagner AD, Grothe W, Haerting J: Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006; 24:2903-2909.
17. Schoffski P: New drugs for treatment of gastric cancer. Ann Oncol 2002; 13: 13-22.
18. Sun P, Xiang JG, Chen ZY: Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg 2009; 96: 26-33.
19. Hartgrink HH, Van de Velde CJ, Putter H: Neo-adjuvant chemotherapy for operable cancer: long-term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 2004; 27: 183-188.
20. MacDonald JS, Cervantes A: New horizons for gastric cancer: commentary. Eur J Cancer Suppl 2006; 4:1-3.